Jeremy R. Graff - Net Worth and Insider Trading
Jeremy R. Graff Net Worth
The estimated net worth of Jeremy R. Graff is at least $755 dollars as of 2024-11-29. Jeremy R. Graff is the Director of IN8bio Inc and owns about 2,500 shares of IN8bio Inc (INAB) stock worth over $755. Details can be seen in Jeremy R. Graff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeremy R. Graff has not made any transactions after 2023-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeremy R. Graff
Jeremy R. Graff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy R. Graff owns 1 companies in total, including IN8bio Inc (INAB) .
Click here to see the complete history of Jeremy R. Graff’s form 4 insider trades.
Insider Ownership Summary of Jeremy R. Graff
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INAB | IN8bio Inc | 2023-09-13 | director |
Jeremy R. Graff Latest Holdings Summary
Jeremy R. Graff currently owns a total of 1 stock. Jeremy R. Graff owns 2,500 shares of IN8bio Inc (INAB) as of September 13, 2023, with a value of $755.
Latest Holdings of Jeremy R. Graff
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INAB | IN8bio Inc | 2023-09-13 | 2,500 | 0.30 | 755 |
Holding Weightings of Jeremy R. Graff
Jeremy R. Graff Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeremy R. Graff has made a total of 1 transactions in IN8bio Inc (INAB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IN8bio Inc is the acquisition of 2,500 shares on September 13, 2023, which cost Jeremy R. Graff around $2,375.
Insider Trading History of Jeremy R. Graff
- 1
Jeremy R. Graff Trading Performance
GuruFocus tracks the stock performance after each of Jeremy R. Graff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeremy R. Graff is 52.05%. GuruFocus also compares Jeremy R. Graff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeremy R. Graff within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeremy R. Graff's insider trading performs compared to the benchmark.
Performance of Jeremy R. Graff
Jeremy R. Graff Ownership Network
Jeremy R. Graff Owned Company Details
What does IN8bio Inc do?
Who are the key executives at IN8bio Inc?
Jeremy R. Graff is the director of IN8bio Inc. Other key executives at IN8bio Inc include Chief Financial Officer Patrick Mccall , director & President & CEO and CFO William Tai-wei Ho , and director & 10 percent owner Bios Fund Ii, Lp .
IN8bio Inc (INAB) Insider Trades Summary
Over the past 18 months, Jeremy R. Graff made 1 insider transaction in IN8bio Inc (INAB) with a net purchase of 2,500. Other recent insider transactions involving IN8bio Inc (INAB) include a net purchase of 23,800 shares made by William Tai-wei Ho , a net purchase of 1,000 shares made by Patrick Mccall ,
In summary, during the past 3 months, insiders sold 0 shares of IN8bio Inc (INAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IN8bio Inc (INAB) were sold and 27,300 shares were bought by its insiders, resulting in a net purchase of 27,300 shares.
IN8bio Inc (INAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
IN8bio Inc Insider Transactions
Jeremy R. Graff Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy R. Graff. You might contact Jeremy R. Graff via mailing address: C/o In8bio, Inc., 350 5th Avenue, Suite 5330, New York Ny 10118.